(Q40794512)

23 September 2017

Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides (English)

1 reference

inflammatory bowel diseases

23 September 2017

0 references

author name string

Turunen U

1

1 reference

23 September 2017

Elomaa I

2

1 reference

23 September 2017

Anttila VJ

3

1 reference

23 September 2017

Seppälä K

4

1 reference

23 September 2017

1 September 1987

1 reference

Scandinavian Journal of Gastroenterology

23 September 2017

1 reference

23 September 2017

22

1 reference

23 September 2017

798-802

1 reference

23 September 2017

7

1 reference

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

23 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365528708991917

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365528708991917

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365528708991917

Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365528708991917

An oral preparation to release drugs in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365528708991917

10.3109/00365528708991917

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference